Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus. Their study in mice sheds light on the unexplored “dark side” of the ...

A two-dose HIV vaccine generated antibodies against the virus in 35 out of 36 people (97 per cent), with no severe side effects. The early-stage trial was designed to demonstrate safety and a proof-of ...

An underexplored part of the flu viruses — the "dark side" of a specific protein — is likely a good target for universal flu vaccines. When you purchase through links on our site, we may earn an ...

A newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune patient samples from samples of patients previously infected with the related dengue virus. The ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

By Hugo Francisco de Souza By combining nationwide health data with elegant immunology experiments, researchers reveal how ...

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV ...

A positive rubella IgG test indicates immunity to rubella, meaning that the pregnant person and the fetus cannot contract this virus. If a person contracts rubella, also known as German measles, ...